The EMBER Trial for Weight Management Engagement
1 other identifier
interventional
470
1 country
2
Brief Summary
This study will test whether EMBER, a self-help tool to increase weight loss treatment engagement, helps veterans engage in Veterans Health Administration (VHA) weight management programs. Participants will be randomly assigned to receive EMBER or a list of weight management programs (the control group). They will answer questions about health beliefs and behaviors and share information from their medical record at the start of the study, 2-months after the start of the study, and 6-months after the start of the study. Participants will receive compensation for each of these contacts. Participants will also receive a reminder call 10 days after they enroll in the study. All study contacts will be over the phone. The main hypothesis is that people who receive EMBER will be more likely to use VHA weight management programs than people in the control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable obesity
Started Sep 2022
Typical duration for not_applicable obesity
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 10, 2022
CompletedFirst Posted
Study publicly available on registry
June 21, 2022
CompletedStudy Start
First participant enrolled
September 19, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 29, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2025
CompletedResults Posted
Study results publicly available
May 22, 2026
CompletedMay 22, 2026
April 1, 2026
2.2 years
June 10, 2022
March 12, 2026
April 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Weight Management Use
Dichotomous variable representing whether participant has 1+ VA weight management visits in the 2 months after baseline, per administrative data and/or self-report of use of VA weight management programs via single item question.
2-months post randomization
Secondary Outcomes (9)
Weight Management Use
6-months post randomization
Number of Weight Management Visits
6-months post-randomization
New Weight Management Behavior
2-months post randomization
New Weight Management Behavior
6-months post randomization
Quality of Life (Veterans RAND 12 Item Health Survey (VR-12))
2--months post randomization
- +4 more secondary outcomes
Study Arms (2)
EMBER
EXPERIMENTALSelf-help tool to increase weight management engagement
Control
ACTIVE COMPARATORList of treatments
Interventions
Eligibility Criteria
You may qualify if:
- Veteran using primary care at VA Palo Alto or Houston in prior year
- BMI greater than or equal to 30 kg/m2
You may not qualify if:
- Age 80 or older
- Documentation of a suicide attempt in the past 30 days
- Hospitalization in the past 30 days
- Documentation or other evidence of cognitive impairment
- VA weight management program use in past 2 years
- Self-report from potential participant that they will not be in town for the majority of the 2 months following baseline
- Self-report from potential participant they plan to leave VA Palo Alto or Houston within the next 6 months
- Under age 18
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
VA Palo Alto Health Care System, Palo Alto, CA
Palo Alto, California, 94304-1207, United States
Michael E. DeBakey VA Medical Center, Houston, TX
Houston, Texas, 77030-4211, United States
Related Publications (1)
Breland JY, Fletcher TL, Maguen S, Timko C, Raikov I, Boothroyd DB, Frayne SM. The EMBER trial for weight management engagement: A hybrid type 1 randomized controlled trial protocol. Contemp Clin Trials. 2023 Dec;135:107364. doi: 10.1016/j.cct.2023.107364. Epub 2023 Oct 24.
PMID: 37884122BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Jessica Breland, Principal Investigator
- Organization
- VA Palo Alto Health Care System
Study Officials
- PRINCIPAL INVESTIGATOR
Jessica Yelena Breland, PhD MS BA
VA Palo Alto Health Care System, Palo Alto, CA
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Participant outcomes will be assessed by an outside company with no knowledge of randomization status.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 10, 2022
First Posted
June 21, 2022
Study Start
September 19, 2022
Primary Completion
November 29, 2024
Study Completion
March 31, 2025
Last Updated
May 22, 2026
Results First Posted
May 22, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Datasets will be available within 1 year of publication.
- Access Criteria
- Datasets meeting VA standards for disclosure to the public will be made available within 1 year of publication. Prior to distribution, a local privacy officer will certify that all datasets contains no PHI. Final data sets will be maintained locally until enterprise-level resources become available for long-term storage and access. Guidance on request and distribution processes will be provided by VA Office of Research \& Development (ORD). Those requesting data will be asked to sign a Letter of Agreement.
A de-identified, anonymized dataset will be created and shared with qualified investigators.